Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Skull Base Institute (SBI) is a specialized medical facility dedicated to the treatment of complex brain and skull base disorders through minimally invasive surgical techniques. Founded by Dr. Hrayr Shahinian, the institute is a pioneer in the field of endoscopic 'keyhole' neurosurgery, which avoids the need for traditional large-scale craniotomies. SBI focuses on treating a variety of conditions, including pituitary tumors, acoustic neuromas, meningiomas, and trigeminal neuralgia. By utilizing advanced high-definition endoscopic technology, the institute aims to minimize brain trauma and significantly reduce patient recovery times. The facility serves a global patient base, offering comprehensive diagnostic and surgical services. SBI remains at the forefront of neurosurgical innovation, emphasizing safety and improved clinical outcomes for patients with deep-seated brain lesions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skull Base Institute.